A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.
about
Occurrence of virulence-associated properties in Enterobacter cloacaeKlebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsThe neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African childrenIdentification of a domain in Rck, a product of the Salmonella typhimurium virulence plasmid, required for both serum resistance and cell invasionInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyInfectious diseases associated with complement deficiencies.TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.Bactericidal activity of human serum against Escherichia coli chi1776.Modification of bacterial serum susceptibility by rifampinMoraxella catarrhalis: from emerging to established pathogen.In vitro interaction of Bacteroides fragilis with polymorphonuclear leukocytes and serum factors.Extraintestinal Campylobacter infections.Plasmid-mediated resistance to the bactericidal effects of normal rabbit serumPenicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infectionProtective role of complement in experimental Escherichia coli endocarditisFunctional role of antibody against "core" glycolipid of Enterobacteriaceae.Escherichia coli bacteremia in the squirrel monkey. I. Effect of cobra venom factor treatmentSustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.ArcA-regulated glycosyltransferase lic2B promotes complement evasion and pathogenesis of nontypeable Haemophilus influenzae.Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coliMechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypesPhagocytosis and intracellular killing of the contagious equine metritis organism by equine neutrophils in serum.Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.Nucleotide sequence analysis of the complement resistance gene from plasmid R100.Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice.Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.Experimental Escherichia coli endocarditis in rats: roles of serum bactericidal activity and duration of catheter placement.Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serumInhibition of serum bactericidal reaction by lipopolysaccharide.Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serumSensitivity of Capnocytophaga species to bactericidal properties of human serum.
P2860
Q24528176-402051C1-E5B1-407C-91EF-1316805114DEQ24550738-1DF69C41-276F-4B9F-8EC8-344539688D06Q24651695-36FBAC62-8B41-4091-A7E9-3172B4638172Q24670046-91A6AE75-6868-4E64-913C-FC8298693F4FQ28972389-5192A760-7A4C-45C8-8724-7A5947A874EBQ30450183-23107FF0-57BE-48C0-9EE1-144360CE6641Q33606633-1F6EB8A5-141E-4C9E-8B13-5328F5480121Q33627395-F423FC77-0336-4066-AE91-0855C7BE9CBDQ33903957-252B75E3-0B96-4BB0-974A-86F63DA239A9Q33904156-7E5065CC-01C7-4059-9E55-665D668E53AAQ33906182-42A416B8-2DB8-42A7-9733-EF17B2FEFAD4Q34115000-8380C963-51DC-4372-9A94-64041D075194Q34193499-AFE34FB8-FF87-4D03-A2F4-ECEF3F15F5FFQ34405630-179230BA-FE45-439B-BBB5-547C68B39C9DQ34427461-D18AB260-5A39-488A-B801-6C2351480C08Q34430332-29720B3B-9771-4024-A60A-6C35B7CBC375Q34482763-D28D74B8-1304-47C5-88AE-CD23B48D7E71Q34499196-A8EB5BCA-139F-470C-B7DA-D87CEDE07003Q34760675-C0D19FED-1012-444D-A909-74010E40C977Q34932063-720136B9-376A-45EC-8384-6C41CD12AA73Q35272921-CDA24477-F436-4F2E-963A-5F31B6655600Q35751833-20DE7E9C-8F72-43FB-B2F6-390FA9EFF9DEQ35822024-E931A93B-1AD6-47E8-8996-DED5CD992666Q35850975-26EDFC4C-1CAA-4D61-A5E4-97573E8139A3Q35905135-CE4C14D4-5936-475A-B8AC-CC4A3F3ACF9CQ36184367-BC8542AE-085E-4FEA-ACF7-C1991C5C9A03Q36303453-983A779D-91A5-4DD5-BC9A-55D9DDC6E813Q36328942-5A347567-19E3-4A99-A34F-94C966B8C914Q36333973-C1DCF6E3-5870-4496-B999-3F108DC1F4F3Q36346256-2EE54C74-B4CE-4899-9DE8-A3A4F67D9763Q36346273-BB81E350-E5A3-4F9C-B859-E56397F19051Q36388195-85D0C11E-0DC2-4F7F-BA64-DC54141610A7Q36950874-7006DF07-AF8E-46A4-B401-05E497DB1344Q36955465-71E9F823-F8A9-4B3F-9481-24F9574761A2Q36992338-1A7334B9-71E4-4B61-9094-83C41A374F80Q37004840-5E7D8EE0-A6DB-4969-A30D-095F9CF96F02Q37016047-0E81AE02-551A-46AC-8DB4-268C371E56BAQ37033712-9C0D2382-1CFF-48DE-AE5D-55AA6A5F144DQ37049326-275EC8C3-EDAC-4AA3-A313-7420CDDE0C08Q37052911-A6122DA0-5177-4782-9D93-2C99D6CB8A73
P2860
A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.
description
1960 nî lūn-bûn
@nan
1960 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1960 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1960年の論文
@ja
1960年論文
@yue
1960年論文
@zh-hant
1960年論文
@zh-hk
1960年論文
@zh-mo
1960年論文
@zh-tw
1960年论文
@wuu
name
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@ast
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@en
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@nl
type
label
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@ast
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@en
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@nl
prefLabel
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@ast
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@en
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@nl
P2860
P356
P1476
A STUDY OF THE RELATIONSHIP OF ...... SERUM TO BACTERIAL INFECTION.
@en
P2093
P2860
P356
10.1172/JCI104029
P407
P577
1960-01-01T00:00:00Z